An announcement from Photocure ASA ( ($PHCUF) ) is now available. Photocure ASA has partnered with Intelligent Scopes Corporation to develop AI ...

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that it has entered into a partnership with Intelligent Scopes Corporation (ISC) to develop Artificial Intelligence (AI) software with ...

Bladder cancer is one of the most common urological cancers, with nonmuscle invasive forms accounting for a significant portion of new diagnoses. In September, UC Davis Comprehens ...

Inlexzo is supplied as a single-dose intravesical system containing 225mg of gemcitabine plus a sterile urinary catheter and stylet.

When using a diagnostic tool, it is common see to more false-positives as the number of true-positives increases ( Table 1). The accuracy of fluorescence cystoscopy is also affected by previous ...

As September concludes, the landscape of GU oncology continues to evolve, with important developments in prostate, bladder, ...

Bladder cancer affects 75,000 people in this country every year, but treating it can bring drastic change to patients. So now, Bay Area surgeons are offering a new option -- the neobladder procedure.

Please provide your email address to receive an email when new articles are posted on . A urinary DNA methylation test outperformed the nuclear matrix protein 22 test or urine cytology test.

Bladder cancer affects approximately 83,000 Americans each year, yet remains one of the most overlooked forms of cancer despite having excellent survival rates when caught early. This disconnect ...